Meet Kunwoo Lee, GenEdit Founder — Bio + How to Reach Out

Last updated: 2025-11-08

Who is Kunwoo Lee?

Kunwoo Lee, Ph.D., is the CEO and co-founder of GenEdit, a biotech company focused on developing innovative gene therapies through targeted delivery of genetic medicines. He has a strong background in bioengineering and biomedical engineering, with extensive research collaborations with Nobel Laureate Jennifer Doudna.

Kunwoo Lee's Work History

Kunwoo Lee has been the CEO and co-founder of GenEdit since 2016. He previously pursued doctoral research at UC Berkeley and UCSF, specializing in bioengineering and biomedical engineering. His work focuses on overcoming delivery challenges in gene therapy and advancing CRISPR-based therapeutics.

• 2016-05-01 - Chief Executive Officer & Co-founder, GenEdit

Kunwoo Lee's Education

Kunwoo Lee earned his Ph.D. in Bioengineering and Biomedical Engineering from UC Berkeley, where he conducted pioneering research on gene delivery technologies. He also completed his doctoral studies at UCSF, focusing on genetic medicine and nanotechnology.

• UC Berkeley - Doctor of Philosophy - PhD in Bioengineering and Biomedical Engineering (2011 - 2016)
• UCSF - Doctor of Philosophy (Ph.D.) in Bioengineering and Biomedical Engineering (2011 - 2016)

About GenEdit

GenEdit is a biotech company dedicated to transforming gene therapy delivery through its proprietary nanoparticle platform. Its mission is to develop safe, effective genetic medicines for various diseases, leveraging advanced nanotechnology and gene editing techniques.

GenEdit Funding

GenEdit secured seed funding from Sequoia Capital and investment from Eli Lilly. In 2024, it signed a licensing deal worth approximately USD 584.5 million with Genentech.

How to Reach Kunwoo Lee?

You can reach Kunwoo Lee at *******@genedit.com or by calling +1 **********. To get Kunwoo Lee's contact information and other startup founders like this, sign up for a free account at Anybody.com.